Replies to post #119630 on Biotech Values

[DewDiligence]

The rate of [Lovenox] usage is going up. Unless you have some big contra-indication, most patients end up on the prophylaxis dose. I think the government is monitoring hospitals rate of nosocomial DVT for acute care patients.

Medicare has threatened to cut off reimbursement for hospital-induced problems (see, for instance, the 2007 WSJ piece in http://online.wsj.com/article/SB118757136042602491.html ), but I didn’t know whether these threats had actually altered behavior. You’re saying they have, which ought to be a good thing.